article

1. Nutritional Aspects to Cardiovascular Diseases and Type 2 Diabetes Mellitus..  Current cardiology reports.  26:73-81. 2024
2. Time of eating and mortality in U.S. adults with heart failure: Analyses of the National Health and Nutrition Examination Survey 2003-2018..  Nutrition, metabolism, and cardiovascular diseases : NMCD.  34:445-454. 2023
3. Objectively Measured Night-Time Sleep Efficiency and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction..  The American journal of cardiology.  124-125. 2023
4. Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction..  Journal of the American Heart Association.  12:-. 2023
5. Life's Essential 8: Optimizing Health in Older Adults..  JACC. Advances.  2. 2023
6. Skeletal muscle quality, measured via phase angle, and cardiorespiratory fitness in patients with obesity and heart failure with preserved ejection fraction..  Nutrition (Burbank, Los Angeles County, Calif.).  -. 2023
7. Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra..  Cells.  12. 2023
8. The effect of time of eating on cardiometabolic risk in primary and secondary prevention of cardiovascular disease..  Diabetes/metabolism research and reviews.  40:-. 2023
9. Fast Today, Feast Tomorrow: Can Intermittent Fasting Improve Right Ventricular Function in Pulmonary Arterial Hypertension?.  JACC. Basic to translational science.  8:255-257. 2023
10. Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction..  The international journal of cardiovascular imaging.  39:811-819. 2023
11. Contribution of hemoglobin concentration to cardiorespiratory fitness in black African American patients with recently decompensated heart failure and reduced ejection fraction..  Minerva cardiology and angiology.  71:456-462. 2022
12. Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction..  Cardiology clinics.  40:491-506. 2022
13. Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction..  Circulation. Heart failure.  15:-. 2022
14. Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014..  PloS one.  17:-. 2022
15. Effects of Replacing Sedentary Time With Physical Activity on Mortality Among Patients With Heart Failure: National Health and Nutrition Examination Survey Follow-Up Study..  Mayo Clinic proceedings.  97:1897-1903. 2022
16. Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease..  European heart journal. Quality of care & clinical outcomes.  8:361-367. 2022
17. Sleeve Gastrectomy Reduces BMI and Pill Count in Patients With LVAD..  Journal of cardiovascular pharmacology.  79:644-645. 2022
18. Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure..  The American journal of cardiology.  61-67. 2022
19. Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity..  International journal of cardiology.  23-27. 2022
20. Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure..  Journal of cardiopulmonary rehabilitation and prevention.  42:39-44. 2022
21. Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study..  Journal of cardiovascular pharmacology.  78:407-410. 2021
22. Preservation of Cardiac Reserve and Cardiorespiratory Fitness in Patients With Acute De Novo Versus Acute on Chronic Heart Failure With Reduced Ejection Fraction..  The American journal of cardiology.  74-80. 2021
23. Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest Radiation..  Lung.  199:403-407. 2021
24. Time of eating and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction and obesity..  Nutrition, metabolism, and cardiovascular diseases : NMCD.  31:2471-2473. 2021
25. Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus..  Journal of the American Heart Association.  10:-. 2021
26. Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure..  Journal of cardiovascular pharmacology.  77:49-60. 2020
27. Left ventricular concentric remodeling and impaired cardiorespiratory fitness in patients with heart failure and preserved ejection fraction..  Minerva cardiology and angiology.  69:438-445. 2020
28. Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction..  Frontiers in endocrinology.  -. 2020
29. The role of diet and nutrition in heart failure: A state-of-the-art narrative review..  Progress in cardiovascular diseases.  63:538-551. 2020
30. Nutrition, Heart Failure, and Quality of Life: Beyond Dietary Sodium..  JACC. Heart failure.  8:765-769. 2020
31. The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study..  Diabetes/metabolism research and reviews.  36:-. 2020
32. Time restricted feeding: old tools, new packaging?.  Minerva cardioangiologica.  68:539-541. 2020
33. Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy..  Cardio-oncology (London, England).  -. 2020
34. Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors..  The American journal of cardiology.  125:988-996. 2019
35. The Effects of Dietary Sugars on Cardiovascular Disease and Cardiovascular Disease-Related Mortality: Finding the Sweet Spot..  Mayo Clinic proceedings.  94:2375-2377. 2019
36. Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty..  Nutrients.  11. 2019
37. Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions..  The American journal of cardiology.  125:76-81. 2019
38. Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study..  JACC. Basic to translational science.  4:563-565. 2019
39. Obesity paradox in cardiovascular disease: where do we stand?.  Vascular health and risk management.  89-100. 2019
40. Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia..  Current problems in cardiology.  45:-. 2019
41. Potential role for interleukin-1 in the cardio-renal syndrome..  European journal of heart failure.  21:385-386. 2019
42. C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction..  Frontiers in cardiovascular medicine.  -. 2018
43. Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  17:2132-2133. 2018
44. Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance..  The American journal of cardiology.  123:466-473. 2018
45. Dietary Fats and Chronic Noncommunicable Diseases..  Nutrients.  10. 2018
46. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction..  Circulation. Heart failure.  11:-. 2018
47. Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials..  Journal of cardiovascular pharmacology.  72:68-70. 2018
48. Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?.  Lancet (London, England).  391:-. 2018
49. Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics..  Diabetes, obesity & metabolism.  20:2014-2018. 2018
50. The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED..  Nutrition & diabetes.  8:-. 2018
51. The Mediterranean Diet to Treat Heart Failure: A Potentially Powerful Tool in the Hands of Providers..  JACC. Heart failure.  6:-. 2018
52. Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction..  ESC heart failure.  5:372-378. 2018
53. Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction..  JACC. Basic to translational science.  2:513-525. 2017